VREO.CN - Vireo Health International Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
2.0300
+0.0100 (+0.50%)
As of 2:32PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close2.0200
Open2.0200
Bid2.0200 x 0
Ask2.0600 x 0
Day's Range1.8900 - 2.0500
52 Week Range1.5500 - 6.8700
Volume126,672
Avg. Volume125,082
Market Cap171.766M
Beta (3Y Monthly)8.19
PE Ratio (TTM)N/A
EPS (TTM)-0.0830
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Benzinga

    Vireo Health Reports Q2 Revenue Up 70% Year-Over-Year

    Cannabis company Vireo Health International, Inc. (CNSX: VREO) (OTC: VREOF) reported second-quarter total revenue of .2 million, up 70% from the same quarter in 2018. Vireo Health had a net loss in the second quarter of around $1.9 million, compared to a net income of $120,080 in the same quarter of 2018. Additional business updates after the second quarter, include promoting Christian Gonzalez to the position of Vice President of enterprise-wide Manufacturing in July and the stock's beginning of trading on the OTCQX Best Market in August.

  • Vireo Health to Report Second Quarter 2019 Results on August 29, 2019
    PR Newswire

    Vireo Health to Report Second Quarter 2019 Results on August 29, 2019

    MINNEAPOLIS , Aug. 21, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading science-focused, multi-state cannabis company, ...

  • Vireo Health Affiliate Given Green Light to Operate Medical Cannabis Processing Facility in Ohio
    PR Newswire

    Vireo Health Affiliate Given Green Light to Operate Medical Cannabis Processing Facility in Ohio

    MINNEAPOLIS, Aug. 15, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO, OTCQX: VREOF), a leading physician-led, science-focused multi-state cannabis company, today announced that the Company's affiliate, Ohio Medical Solutions ("OMS"), was granted a Certificate of Operation by the Ohio Department of Commerce. OMS, which will begin operating immediately, was previously awarded a provisional processing license.

  • Vireo Health to Present at the 39th Annual Canaccord Genuity Growth Conference
    PR Newswire

    Vireo Health to Present at the 39th Annual Canaccord Genuity Growth Conference

    MINNEAPOLIS , Aug. 6, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading physician-led, science-focused, multi-state ...

  • OTC Markets Group Welcomes Vireo Health International Inc. to OTCQX
    PR Newswire

    OTC Markets Group Welcomes Vireo Health International Inc. to OTCQX

    NEW YORK , Aug. 2, 2019 /PRNewswire/ -- OTC Markets Group Inc.  (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Vireo Health International Inc. (CSE: ...

  • Vireo Health Subordinate Voting Shares Approved for Inclusion on the OTCQX® Best Market
    PR Newswire

    Vireo Health Subordinate Voting Shares Approved for Inclusion on the OTCQX® Best Market

    Shares will begin trading under ticker symbol "VREOF" on August 2 MINNEAPOLIS , Aug. 1, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: ...

  • Vireo Health Files Patent for Multichannel Vaporizer
    PR Newswire

    Vireo Health Files Patent for Multichannel Vaporizer

    MINNEAPOLIS, July 25, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (VREO.CN), a leading physician-led, science-focused multi-state cannabis company, today announced that the Company filed a patent application with United States Patent and Trademark Office ("USPTO") for a multichannel vaporizer designed to hold at least two vaporizer cartridges. The device will allow a user to adjust the mixture of vapor coming from each cartridge using a simple interface. Currently, if a consumer or patient wants to use more than one vaporizer formulation, he or she needs to purchase a separate vaporizer cartridge for each formulation.

  • Vireo Health CEO Kyle Kingsley, M.D. responds to U.S. Senate Committee on Banking, Housing and Urban Affairs Hearing on Challenges for Cannabis and Banking
    PR Newswire

    Vireo Health CEO Kyle Kingsley, M.D. responds to U.S. Senate Committee on Banking, Housing and Urban Affairs Hearing on Challenges for Cannabis and Banking

    MINNEAPOLIS , July 23, 2019 /PRNewswire/ --   The following statement can be attributed to Dr. Kyle Kingsley , Chief Executive Officer of Vireo Health International, Inc. ("Vireo" or the "Company") ...

  • Vireo Health Launches New York's First Same-Day Marijuana Delivery Service
    PR Newswire

    Vireo Health Launches New York's First Same-Day Marijuana Delivery Service

    NEW YORK, July 16, 2019 /PRNewswire/ -- Vireo Health of New York ("Vireo" or the "Company"), a subsidiary of Vireo Health International (VREO.CN), a leading physician-led, science-focused multi-state cannabis company, today announced that patients living in the New York City metro area, Westchester County, and Nassau County now have access to free, same-day marijuana delivery. Launched in April 2017, Vireo's medical marijuana home delivery service has rapidly expanded. Since its inception, the Company has made more than 25,000 home deliveries to patients.

  • CNW Group

    Horizons ETFs Rebalances Marijuana-Focused ETFs

    Horizons ETFs Rebalances Marijuana-Focused ETFs

  • Vireo Health Announces Inclusion in Horizons Marijuana Index ETFs
    PR Newswire

    Vireo Health Announces Inclusion in Horizons Marijuana Index ETFs

    MINNEAPOLIS , June 27, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), a leading science-focused, multi-state cannabis company, ...

  • Vireo Health to Present at MJ Micro Conference in New York on June 25
    PR Newswire

    Vireo Health to Present at MJ Micro Conference in New York on June 25

    MINNEAPOLIS , June 24, 2019 /PRNewswire/ --   Vireo Health International, Inc. ("Vireo" or the "Company") (CSE: VREO), a leading science-focused, multi-state cannabis company, today ...

  • Vireo Health Expands into Puerto Rico's Rapidly Growing Medical Cannabis Market
    PR Newswire

    Vireo Health Expands into Puerto Rico's Rapidly Growing Medical Cannabis Market

    MINNEAPOLIS, June 20, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (VREO.CN), a leading physician-led, science-focused multi-state cannabis company, today announced the acquisition of medical cannabis licenses in the Commonwealth of Puerto Rico. The acquisition is comprised of pre-approvals for licenses to cultivate, process, and sell cannabis products and operate up to six dispensaries. This transaction marks the eleventh market in which Vireo is licensed to grow, manufacture, or sell cannabis products.

  • Newsfile

    Vireo Health International Inc., A Patent with Potential to Disrupt the Global Tobacco Industry, CEO Clip Video

    Vancouver, British Columbia--(Newsfile Corp. - June 6, 2019) - CEO of Vireo Health, Kyle Kingsley M.D, speaks about the cannabis company's patent that covers the protective effects of cannabinoids when mixed with tobacco.If you cannot view the video above, please visit:https://www.b-tv.com/vireo-health-10-state-operator-ceo-clip-90sec/Vireo Health is being featured on BNN Bloomberg on June 8 - June 9, 2019, throughout the day and evenings.Vireo Health International Inc. (CSE: VREO)vireohealth.comAbout CEO Clips:CEO Clips is the largest library of publicly ...

  • Vireo Health to Present at Upcoming Conference Events
    PR Newswire

    Vireo Health to Present at Upcoming Conference Events

    MINNEAPOLIS , June 3, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CSE: VREO), a leading science-focused, multi-state cannabis company, today announced ...

  • Vireo Health Announces First Quarter 2019 Financial Results
    PR Newswire

    Vireo Health Announces First Quarter 2019 Financial Results

    -- Pro forma Q1 revenue of approximately $7.0 million -- -- Total revenue of $5.8 million increased approximately 57 percent year-over-year -- -- Minnesota passes law doubling number of licensed dispensaries ...

  • Harris Rabin, former ABInBev & Bayer leader, joins Vireo Health as Chief Marketing Officer
    PR Newswire

    Harris Rabin, former ABInBev & Bayer leader, joins Vireo Health as Chief Marketing Officer

    NEW YORK, May 29, 2019 /PRNewswire/ -- Vireo Health International, Inc. (VREO.CN), a leading science-focused, multi-state cannabis company, today announced Harris Rabin will be joining the company's executive team in the newly created role of Chief Marketing Officer. Rabin will be overseeing brand marketing, e-commerce, and sales efforts.

  • Vireo Health to Report First Quarter 2019 Results on May 31, 2019
    PR Newswire

    Vireo Health to Report First Quarter 2019 Results on May 31, 2019

    MINNEAPOLIS , May 21, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CSE: VREO), a leading science-focused, multi-state cannabis company, today announced ...

  • Vireo Health Announces Board Of Directors
    PR Newswire

    Vireo Health Announces Board Of Directors

    MINNEAPOLIS, May 16, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo Health" or the "Company") (VREO.CN), a leading science-focused, multi-state cannabis company, today announced the addition of four new Directors to the Company's Board and the formation of three committees to provide oversight and guidance on Audit, Compensation, and other Corporate Governance matters. "I am honored to join the Vireo Health Board of Directors and offer my consumer branding expertise to a leader in the rapidly growing cannabis industry," said Chelsea A. Grayson, Vireo Health Director and CEO of True Religion Brand Jeans.

  • Vireo Health to Present at Canaccord Genuity's 3rd Annual Cannabis Conference
    PR Newswire

    Vireo Health to Present at Canaccord Genuity's 3rd Annual Cannabis Conference

    MINNEAPOLIS , May 10, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CSE: VREO), a leading science-focused, multi-state cannabis company, today announced ...

  • Vireo Health Announces Full Year 2018 Revenues of $18.5 Million with 70% Year-Over-Year Growth
    PR Newswire

    Vireo Health Announces Full Year 2018 Revenues of $18.5 Million with 70% Year-Over-Year Growth

    - Company raised $51.4 million through reverse takeover transaction (RTO) in March - - Successful closing of five acquisitions year-to-date establishes 10-state, nationwide footprint - - Green Goods™ dispensary ...

  • Vireo Health to Report Fourth Quarter and Full Year 2018 Results on April 30, 2019
    PR Newswire

    Vireo Health to Report Fourth Quarter and Full Year 2018 Results on April 30, 2019

    MINNEAPOLIS , April 26, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CSE: VREO), a leading science-focused, multi-state cannabis company, today ...

  • Vireo Health's Patent Application For Less Harmful Tobacco Products Infused With Cannabis Is Approved By USPTO
    PR Newswire

    Vireo Health's Patent Application For Less Harmful Tobacco Products Infused With Cannabis Is Approved By USPTO

    Vireo's allowed patent application covers cannabis-based additives that can be formulated into tobacco products to reduce the harm associated with tobacco use. This novel application of cannabis covers the use of one or more carefully formulated cannabinoids as harm reducing agents in tobacco products such as cigarettes, cigars, pipe tobacco and smokeless tobacco products.

  • Vireo Health CEO & Founder Kyle Kingsley, M.D. to Present at Two Upcoming Cannabis Investor Conferences
    PR Newswire

    Vireo Health CEO & Founder Kyle Kingsley, M.D. to Present at Two Upcoming Cannabis Investor Conferences

    MINNEAPOLIS , April 15, 2019 /PRNewswire/ --   Vireo Health International, Inc. ("Vireo" or the "Company") (CSE: VREO), a leading science-focused, multi-state cannabis company, today ...

  • Vireo Health Now Licensed to Operate in Ten States with Acquisition of Nevada Cannabis Company
    PR Newswire

    Vireo Health Now Licensed to Operate in Ten States with Acquisition of Nevada Cannabis Company

    MINNEAPOLIS, April 11, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (VREO.CN), America's leading science-focused, multi-state cannabis company, today announced the acquisition of two medical cannabis licenses in the State of Nevada. The licenses, which are conditionally approved for adult-use cannabis, will enable Vireo to cultivate, manufacture, and wholesale cannabis-based products to Nevada's licensed dispensaries.